secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2026-01-08T23:59:59+00:00
Accession:  0001615219-26-000013
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Salarius Pharmaceuticals renames to Decoy Therapeutics; ticker changes to DCOY effective Jan 8, 2026
--------------------------------------------------------------------------------

- Name change to Decoy Therapeutics Inc. and ticker symbol change from SLRX to DCOY effective January 8, 2026.
- No change to shares outstanding, shareholder rights, CUSIP number, or transfer agent.
- Focus on AI-enabled peptide-conjugate platform; lead antiviral program attracts BARDA interest.
- 2026 priorities: advance lead into clinic, expand pipeline, pursue partnerships, and strengthen capital structure.
- Company to launch new website decoytx.com for investor relations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000161521926000013/0001615219-26-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000161521926000013/flks-20260108.htm
  HTML page:      https://secwatch.observer/filing/0001615219-26-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer